FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
FORT MYERS, Fla., Aug. 31, 2016 -- 21st Century Oncology Holdings, Inc., the largest global, physician led provider of integrated cancer care services, today announced that it has rescheduled its conference call to discuss financial results for the fourth quarter and year ended December 31, 2015 and restated financial statements for prior periods. The conference call has been rescheduled to Tuesday, September 6, 2016 at 3:00 p.m. Eastern Time. The conference call and replay of the conference call may be accessed as follows:
Dial-in numbers: 877-407-9039 (Domestic); 201-689-8470 (International)
Replay Dial-in Numbers (Available until September 20, 2016): 877-870-5176 (Domestic); 858-384-5517 (International); Replay Pin Number: 13644461
A live webcast and webcast replay of the call will also be available from the Events section of the corporate web site at www.21co.com.
About 21st Century Oncology Holdings, Inc.
21st Century Oncology Holdings, Inc. is the largest global, physician led provider of integrated cancer care services. The Company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. As of December 31, 2015, the Company operated 181 treatment centers, including 145 centers located in 17 U.S. states and 36 centers located in seven countries in Latin America.
21st Century Oncology Contact: LeAnne M. Stewart Chief Financial Officer 239-931-7281 [email protected] Investor Contact: The Ruth Group Nick Laudico 646-536-7030 [email protected] Brandon Vazquez 646-536-7032 [email protected]
